Diagnostic Approach for Celiac Disease with Low IgA Levels

Immediate Next Steps

When a celiac panel shows low IgA levels, the American Gastroenterological Association recommends immediately ordering IgG-based serologic tests, such as IgG deamidated gliadin peptide (DGP-IgG) or IgG tissue transglutaminase (tTG-IgG), because IgA deficiency renders standard IgA-based celiac testing falsely negative in patients who may actually have celiac disease 1, 2
Verify the total IgA level is truly deficient, typically less than 7 mg/dL or below age-specific reference ranges, as recommended by the American Academy of Family Physicians 3, 2

If IgG-based serology is positive, proceed directly to upper endoscopy with duodenal biopsy to confirm the diagnosis, as suggested by the American Academy of Family Physicians 3, 2
Obtain at least 6 biopsy specimens, including 1-2 from the duodenal bulb and at least 4 from the second part of the duodenum or beyond, as recommended by the American Gastroenterological Association 2, 4
Ensure the patient is consuming adequate gluten, at least 10g daily, at the time of biopsy to avoid false-negative histology, as recommended by the American Gastroenterological Association 2, 4

IgG deamidated gliadin peptide (DGP-IgG) is the preferred test in IgA-deficient patients, with superior diagnostic accuracy (93.6% sensitivity, 99.4% specificity) compared to tTG-IgG, as recommended by the American Gastroenterological Association 2
IgG tissue transglutaminase (tTG-IgG) can also be used, though it has lower sensitivity (40.6-84.6%) and specificity (78.0-89.0%) than DGP-IgG, as reported by the American Gastroenterological Association 2

Follow-up testing should occur at 6 months, 12 months, and annually thereafter, using the same IgG-based antibody tests (DGP-IgG or tTG-IgG) for monitoring dietary compliance and disease activity, as recommended by the American Gastroenterological Association 2, 4